Valuation: Maintain Buy with a revised PT of Rs 110: We expect revenue and earnings to report CAGR of 6.8% and 3.3%, respectively, during FY2020-FY2022E (expect 180 bps margin contraction) owing to current crisis environment led by COVID-19.At the CMP, the stock is trading at12.8x and 11.9xits FY2021E and FY2022E earnings, respectively. Though order intake is expected to be muted in FY2021E, given the strong order book of Rs. 51,970 crore coupled with cash and cash equivalents of Rs. 1400+ crore, we believe the company trades at reasonable valuations.Hence, weretain our Buy rating...